FDA
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Bicara Therapeutics Inc (BCAX)
-
-
-
-
-
-
-
Bicara shares data on lower dose cancer therapy at medical conference
-
-
-
-
-
-
-
Jones Trading Starts Bicara Therapeutics Inc (BCAX) at Buy
-
323,580 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

